Search results
Eli Lilly & Co (NYSE:LLY): Jim Cramer’s Best Weight Loss Stock Pick for 2024
Insider Monkey via Yahoo Singapore Finance· 5 days agoWe recently published a list of the 10 Stocks to Buy and Sell Before the Third Quarter 2024...
Eli Lilly Remains an Equities Outlier
FX Empire via Yahoo Singapore Finance· 1 day agoIt’s no wonder LLY shares are up 54% this year – and they could rise more. MAPsignals data shows how Big Money investors are betting heavily on the...
Watchdog Calls on Eli Lilly to Denounce Supreme Court Puppetmaster’s Firm
Rolling Stone via Yahoo News Singapore· 3 days agoEarlier this year, Rolling Stone reported that the pharmaceutical giant Eli Lilly has employed the...
Eli Lilly Alzheimer's drug approved by US FDA
Reuters via Yahoo Singapore Finance· 4 days ago(Reuters) -The U.S. Food and Drug Administration on Tuesday approved Eli Lilly's treatment for early Alzheimer's, making it the second therapy for...
FDA approves Lilly’s new Alzheimer’s drug after delay
The Hill via Yahoo News Singapore· 4 days agoThe Food and Drug Administration (FDA) on Tuesday approved Eli Lilly’s Alzheimer’s drug, the company...
Eli Lilly (LLY) Gets FDA Nod for Alzheimer's Drug Donanemab
Zacks via Yahoo Singapore Finance· 3 days agoEli Lilly's (LLY) Alzheimer's disease drug, Kisunla (donanemab), wins FDA approval. Kisunla will be...
Biden, Sanders call out Novo Nordisk, Eli Lilly for high drug costs in op-ed
The Hill via Yahoo News Singapore· 4 days agoPresident Biden and Sen. Bernie Sanders (I-Vt.) continued their calls for lowered drug pricing in an...
Fighting words: Lilly and Novo swat back at the Biden/Sanders call for lower GLP-1 prices
Yahoo Finance· 4 days agoNovo CEO Lars Jørgensen has agreed to testify before Sanders' committee in late September. But the...
Joe Biden Suggests Novo Nordisk, Eli Lilly To Lower Prices For Its Popular Obesity Drugs
Benzinga via Yahoo Singapore Finance· 4 days agoThe President of the United States, Joe Biden, and Sen. Bernie Sanders, the Senate Chairman of the...
A New Alzheimer’s Drug May Be the Most Effective One Yet
Time via Yahoo News Singapore· 3 days agoDonanemab, or Kisunla, is the third drug approved to target one of the causes of Alzheimer’s: the...
